vitamin k1 injection
"The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels. Clotting pr"...
- Clinician Information:
vitamin k1 injection Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Vitamin K1 (phytonadione) Injectable Emulsion is a vitamin used to treat conditions resulting from vitamin K deficiency or that interfere with vitamin K activity. It is available in generic form. Common side effects of Vitamin K1 include dizziness, sweating, and pain, swelling, and tenderness at the injection site.
Talk to your doctor about your individual dosage recommendation. Prothrombin-depressing anticoagulants may interact with Vitamin K1. Before taking Vitamin K1 tell your doctor if you have impaired kidney function. If you are pregnant only take Vitamin K1 if clearly needed. Exercise caution if taking Vitamin K1 while breastfeeding.
Our Vitamin K1 (phytonadione) Injectable Emulsion Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
vitamin k1 injection FDA Prescribing Information: Side Effects
Transient "flushing sensations" and "peculiar" sensations of taste have been observed, as well as rare instances of dizziness, rapid and weak pulse, profuse sweating, brief hypotension, dyspnea, and cyanosis.
Pain, swelling, and tenderness at the injection site may occur.
The possibility of allergic sensitivity including an anaphylactoid reaction, should be kept in mind.
Infrequently, usually after repeated injection, erythematous, indurated, pruritic plaques have occurred; rarely, these have progressed to scleroderma-like lesions that have persisted for long periods. In other cases, these lesions have resembled erythema perstans.
Hyperbilirubinemia has been observed in the newborn following administration of phytonadione. This has occurred rarely and primarily with doses above those recommended. (See PRECAUTIONS, Pediatric Use.)
Read the entire FDA prescribing information for vitamin k1 injection (Aqueous Colloidal Solution of Vitamin K1) »
Additional Vitamin K1 Information
- Vitamin K1 Drug Interactions Center: vitamin k inj
- Vitamin K1 Side Effects Center
- Vitamin K1 FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.